🔥🔥🔥Role of #imaging for the management of Anderson-Fabry #cardiomyopathy : from #echofirst to #whyCMR, #yesCT and #cvnuc, why, when and how to use them! Read the new European Society of Cardiology M&PD WG and #EACVI Consensus published in EHJCVI Editor-in-Chief ! Maurizio Pieroni academic.oup.com/ehjcimaging/ad…

Clinical significance of red flags 🚩for different hypertrophic cardiomyopathy phenotype: a deep dive into hypertrophic cardiomyopathy and phenocopies! #hypertrophic #cardiomyopathy #EHJ #cardiotwitter European Society of Cardiology @ESC_journals ow.ly/8g7250UZwFp

🕵️‍♂️First systematic evaluation of the Cardiomyopathy mindset approach, based on red flags 🚩for disease specific diagnosis in HCM. Have a read to our last work ! Maurizio Pieroni Ioannis Skalidis iacopo olivotto Alessia Argiró Giuseppe Limongelli Emanuele Monda Azienda Ospedaliero-Universitaria Careggi Service de cardiologie du CHUV

¡Mucho por hacer!!!👏👏👏

reachmd.com/programs/cme/R… #echofirst #whycmr #hcm #myosininhibitors

🔴Clinical Phenotype and Prognostic Significance of Frailty in #ATTR Transthyretin Cardiac #Amyloidosis 🫀 sciencedirect.com/science/articl… What a collaboration! #CardioEd #Cardiology #CardioTwitter JACC Journals Amyloidosis Amyloidosis Support Amyloidosis Research Consortium Società Italiana di Gerontologia e Geriatria EuGMS - European Geriatric Medicine Society

Precision medicine is arriving to Cardiology and ATTR-CM is a paradigm of this shift. See our latest review on advances in therapies for ATTR-CM published at European Society of Cardiology Journals A pleasure writing this with Esther Glez Lopez and mathew.maurer 👇 (1/6) academic.oup.com/eurheartj/arti…

For all the passionate professionals for cardiovascular imaging, this is your opportunity to mingle with, to network with and to learn from a large community with expertise on 4 modalities. Take advantage and join us! escardio.org/Congresses-Eve… L'Institut del Cor del Germans Trias Asociación de Imagen Cardiaca SEC

Intracardiac Flow Dynamics in MR?🌀 📍MR: ⬆️turbulence, ⬇️vortex organization → inefficient🫀performance 📍MV repair > replacement in restoring physiological flow, but some issues remain 📍Transcatheter procedures may cause remodeling & thrombus risk 🔗 #EHJIMP:

"Not all those who wander are genotype-positive…" Our latest journey leads into the “Middle Earth” of HCM 🗺: genotype-negative patients with a family history. Where genes say little, family history and phenotype speak volumes! doi.org/10.1016/j.jaca… #CardioTwitter #HCM

🔴 Hypertrophic cardiomyopathy: prevalence of disease-specific red flags European Society of Cardiology Journals #Cardiology #CardioEd

academic.oup.com/eurheartj/adva… Rare HCM variants responsive to myosin inhibitors. Check out this case! #echofirst, #HCM #whyCMR

Our #EAPC course on #HCM is now live. Dive deep into cutting-edge research, diagnostic strategies, and personalized treatment. This course equips you with the knowledge to optimize patient care and navigate complex cases with confidence. escelearning.escardio.org/course/30

The new #EAPC Course on HCM is now available. Join now to improve your knowledge about diagnosis and treatment of this cardiomyopathy! escelearning.escardio.org/course/30 #whyCMR #echofirst #hcm European Society of Cardiology

In Fabry disease 👴🏻,♂️sex, classic phenotype and CKD are independent predictors of🫀stage progression! francesca graziani_FG Maria chiara meucci Maurizio Pieroni Giuseppe Limongelli Emanuele Monda Annamaria Del Franco Giulia Iannaccone Antonella Lombardo iacopo olivotto FRANCESCO BURZOTTA ahajournals.org/doi/full/10.11…

Registration now open !! fad.mcrconference.it/enrol/index.ph… #cardiomyopthiesmatter #HCM #echofirst #whycmr

🚨 Our new study in JAHA “Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Balance Between Benefit and Risk” 🫀 We outline a practical, patient-centered approach to exercise in ACM, balancing safety with quality of life. 📖 Read here: doi.org/10.1161/JAHA.1…

The earlyGENE trial is evaluating if Candesartan is effective in preventing DCM onset in carriers of DCM genetic variants without disease. An academic effort of 33 centers in 🇪🇸 &🇳🇱. Today participants 200 & 201 were randomized! One step closer!! Congrats investigators & teams!

Brugada syndrome: Channelopathy and/or Cardiomyopathy? Find out more in our latest article #brugada #cardiomyopathy #whycmr mdpi.com/2035-8148/15/2…

💊 Long-Term Follow-Up Data on Flecainide Use as an Antiarrhythmic in ARVC: A Multicenter Study JACC Journals #Cardiology #CardioEd #EPeeps CardioInfo Maurizio Pieroni